Staphylokinase has distinct modes of interaction with antimicrobial peptides, modulating its plasminogen-activation properties.

The truncated form of staphylokinase (SakΔN10) shows improved affinity for antimicrobial peptides, with two distinct binding surfaces identified. Binding of certain peptides to these surfaces either inhibits or promotes Sak's plasminogen activation properties.

The study used binding assays and molecular docking to analyze interactions between staphylokinase (full-length and truncated) and various antimicrobial peptides, assessing affinity and binding sites.

Understanding how staphylokinase interacts with antimicrobial peptides can inform the development of new therapeutic strategies targeting bacterial infections and modulating plasminogen activation.

The study did not specify the in vivo relevance or clinical implications of these interactions, and the exact physiological concentrations of peptides were not addressed.